Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy

Background: The major limitation of targeted cancer therapy is development of acquired resistance. Intratumoral heterogeneity and coexist of multiple resistance mechanisms make combination therapies targeting one specific mechanism inefficient. Methods: Transcriptional signature obtained from GEO wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ling, Hu, Mengdi, Wang, Tao, Chen, Hongzhuan, Xu, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971167/
https://www.ncbi.nlm.nih.gov/pubmed/31993373
http://dx.doi.org/10.3389/fonc.2019.01503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971167/
https://www.ncbi.nlm.nih.gov/pubmed/31993373
http://dx.doi.org/10.3389/fonc.2019.01503

Ejemplares similares